Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 1928270.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ciprofloxacin is a potent fluoroquinolone antibiotic with in vitro activity against many significant gram-positive and gram-negative ocular pathogens. A review of the experimental studies of this antibiotic shows bactericidal activity, a broad antimicrobial spectrum, and a low incidence of resistance. The growing body of experimental data supports the effectiveness of ciprofloxacin in the treatment of experimental keratitis and suggest that it be evaluated further in ocular infections.
Medical subject headings
- Bacterial Infections
- Ciprofloxacin
- Eye Diseases
- Keratitis